Oaktree Capital Group Holdings GP, LLC - 25 Nov 2024 SCHEDULE 13G Report for BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI)

Filing Manager
Oaktree Capital Group Holdings GP, LLC
Reporting Manager
Oaktree Capital Group Holdings GP, LLC
Security
BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
BTAI
Shares outstanding
52,386,058 shares
Disclosed Ownership
2,724,075 shares
Ownership
5.2%
Form type
SCHEDULE 13G
Filing time
18 Dec 2024, 20:19:12 UTC
Date of event
25 Nov 2024
Next filing
15 May 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Oaktree Capital Group Holdings GP, LLC disclosed 5.2% ownership in BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI) on 25 Nov 2024."

Quick Takeaways

  • Oaktree Capital Group Holdings GP, LLC filed SCHEDULE 13G for BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI).
  • Disclosed ownership: 5.2%.
  • Date of event: 25 Nov 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 18 Dec 2024, 20:19.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Oaktree Fund Advisors, LLC 1.6% 822,944 0 822,944 /s/ Henry Orren Henry Orren / Authorized Signatory
OAKTREE CAPITAL MANAGEMENT LP 3.6% 1,901,131 0 1,901,131 /s/ Henry Orren Henry Orren / Authorized Signatory
Oaktree Capital Group Holdings GP, LLC 5.2% 2,724,075 0 2,724,075 /s/ Henry Orren Henry Orren / Authorized Signatory
Oaktree Capital Holdings, LLC 5.2% 2,724,075 0 2,724,075 /s/ Henry Orren Henry Orren / Authorized Signatory

Sponsored